DA
SYRS

Denali Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Denali Advisors’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,700
Closed -$27.6K – 499
2022
Q4 		$27.6K Buy
+7,700
New +$27.6K 0.01% 282